Introduction de Spineway sur NYSE Alternext

Back

Paris,  14 February 2013– NYSE Euronext (NYX) today announced the listing on NYSE Alternext in Paris of Spineway, a company specialised in surgical implants and instruments used to treat spinal column pathologies.

Founded in 2005, Spineway designs, manufactures and markets leading-edge surgical instruments and implants that make spinal surgery more effective. Based in the Lyon suburb of Bron, the company has a distribution network of 48 specialists serving markets outside France. With nearly 30 employees, Spineway has harnessed its founders’ 15 years of experience to build a worldwide reputation for expertise and technical excellence in its field.

Spineway (ticker: ALSPW) was listed through admission to trading of 2,800,500 existing shares and 595,003 new shares issued as a private placement with qualified investors. The private placement raised a total of €4.9 million.

The admission and issue price of Spineway was set at €7.47 per share. Market capitalisation stood at around €25.4 million on the day of listing.

We are delighted to welcome Spineway to NYSE Alternext, our organized market dedicated to small and mid-size companies - a market with regulations matched to the needs of medtech companies,” said Marc Lefèvre, Head of European Business Development and Client Coverage, Listings Europe, at NYSE Euronext. “Spineway has won worldwide recognition as an expert in spinal column surgery. Today it is raising the capital it needs to grow by listing, which will boost its profile and appeal for investors.”

Spineway Chairman and CEO Stéphane Le Roux added, “We are very happy with Spineway’s stockmarket listing and the success of this first transaction. This important step that will enable us to step up the pace of growth significantly while maintaining the independence we have always with Philippe Laurito - ever since Spineway was founded. We want to thank all of the investors who have taken part for their interest and their trust.”

In seven years, €2.7 billion has been raised on NYSE Alternext, half through secondary issues, by companies from countries including Belgium, Canada, China, France, Italy, Luxembourg, the Netherlands, Spain, the UK and the US. Their marketcapitalisation totals over €6 billion. Today 180 companies are listed on NYSE Alternext.

Press Release Footer

About Euronext 
Euronext is the leading pan-European market infrastructure, connecting European economies to global capital markets, to accelerate innovation and sustainable growth. It operates regulated exchanges in Belgium, France, Ireland, Italy, the Netherlands, Norway and Portugal. With close to 2,000 listed issuers and around €5.8 trillion in market capitalisation as of end June 2022, it has an unmatched blue-chip franchise and a strong diverse domestic and international client base. Euronext operates regulated and transparent equity and derivatives markets, one of Europe’s leading electronic fixed income trading markets and is the largest centre for debt and funds listings in the world. Its total product offering includes Equities, FX, Exchange Traded Funds, Warrants & Certificates, Bonds, Derivatives, Commodities and Indices. The Group provides a multi-asset clearing house through Euronext Clearing, and custody and settlement services through Euronext Securities central securities depositories in Denmark, Italy, Norway and Portugal. Euronext also leverages its expertise in running markets by providing technology and managed services to third parties. In addition to its main regulated market, it also operates a number of junior markets, simplifying access to listing for SMEs.  
For the latest news, follow us on Twitter (twitter.com/euronext) and LinkedIn (linkedin.com/euronext).

Disclaimer
This press release is for information purposes only and is not a recommendation to engage in investment activities. This press release is provided “as is” without representation or warranty of any kind. While all reasonable care has been taken to ensure the accuracy of the content, Euronext does not guarantee its accuracy or completeness. Euronext will not be held liable for any loss or damages of any nature ensuing from using, trusting or acting on information provided. No information set out or referred to in this publication may be regarded as creating any right or obligation. The creation of rights and obligations in respect of financial products that are traded on the exchanges operated by Euronext’s subsidiaries shall depend solely on the applicable rules of the market operator. All proprietary rights and interest in or connected with this publication shall vest in Euronext.

This press release speaks only as of this date. Euronext refers to Euronext N.V. and its affiliates. Information regarding trademarks and intellectual property rights of Euronext is located at www.euronext.com/terms-use.

© 2022, Euronext N.V. - All rights reserved.